↓ Skip to main content

Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

Overview of attention for article published in BMC Cancer, January 2010
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
56 Mendeley